The use of personalized medicine for patient selection for renal transplantation: Physicians' views on the clinical and ethical implications

BMC Medical Ethics 11 (1):5- (2010)
  Copy   BIBTEX

Abstract

BackgroundThe overwhelming scarcity of organs within renal transplantation forces researchers and transplantation teams to seek new ways to increase efficacy. One of the possibilities is the use of personalized medicine, an approach based on quantifiable and scientific factors that determine the global immunological risk of rejection for each patient. Although this approach can improve the efficacy of transplantations, it also poses a number of ethical questions.MethodsThe qualitative research involved 22 semi-structured interviews with nephrologists involved in renal transplantation, with the goal of determining the professionals' views about calculating the global immunological risk and the attendant ethical issues.ResultsThe results demonstrate a general acceptance of this approach amongst the participants in the study. Knowledge of each patient's immunological risk could improve treatment and the post-graft follow-up. On the other hand, the possibility that patients might be excluded from transplantation poses a significant ethical issue. This approach is not seen as something entirely new, given the fact that medicine is increasingly scientific and evidence-based. Although renal transplantation incorporates scientific data, these physicians believe that there should always be a place for clinical judgment and the physician-patient relationship.ConclusionsThe participants see the benefits of including the calculation of the global immunological risk within transplantation. Such data, being more precise and rigorous, could be of help in their clinical work. However, in spite of the use of such scientific data, a place must be retained for the clinical judgment that allows a physician to make decisions based on medical data, professional expertise and knowledge of the patient. To act in the best interests of the patient is key to whether the calculation of the global immunological risk is employed

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 94,549

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Allowing autonomous agents freedom.A. J. Cronin - 2008 - Journal of Medical Ethics 34 (3):129-132.

Analytics

Added to PP
2010-08-24

Downloads
44 (#357,912)

6 months
12 (#312,960)

Historical graph of downloads
How can I increase my downloads?

Author Profiles

Marie-Chantal Fortin
UNIVERSITE DE MONTREAL
Marianne Labrie
Université Laval